Key points from article :
RYSE Asset Management closed a $50 million fund for digital health startups.
Focuses on developing digital diagnostics, digital therapeutics, and medical devices.
The first company funded is Braingaze, a Spanish digital detection and treatment healthtech company.
Braingaze develops apps to diagnose and treat ADHD, autism, dyslexia, Alzheimer's, and mild cognitive impairment.
Their apps use eye-tracking technology for diagnosis and treatment.
RYSE supports Braingaze to get into the NHS and private clinics in the UK, as well as commercialising licensing deals globally.
